TARS
Closed
Tarsus Pharmaceuticals inc
39.99
-0.52 (-1.28%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 40.51
Day's Range: 39.19 - 41.03
Send
sign up or login to leave a comment!
When Written:
12.18
Tarsus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that focuses on developing and commercializing innovative therapies for ophthalmic diseases. The company's lead product candidate, TP-03, is a novel antibiotic and anti-inflammatory combination therapy designed to treat blepharitis, a common eye condition that affects the eyelids. Tarsus Pharmaceuticals was founded in 2017 and is headquartered in Irvine, California. The company went public in August 2020 and is listed on the NASDAQ stock exchange under the ticker symbol TARS.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








